Stanley M. Gartler, Pioneer in Cancer Research, Dies at 102
Stanley M. Gartler, a renowned cancer researcher known for his groundbreaking contributions to the understanding of cancer biology, has passed away at the age of 102. According to The New York Times, Gartler's work fundamentally changed the way scientists view the origins of cancer, establishing that tumors can arise from a single mutated cell.
Gartler's research provided the first convincing evidence supporting the clonal evolution theory of cancer, which posits that cancer develops from a single cell that acquires mutations over time. This pivotal finding has influenced cancer research and treatment strategies, paving the way for targeted therapies that focus on specific genetic alterations within tumors.
Legacy in Cancer Research
In addition to his significant contributions to understanding tumor development, Gartler played a crucial role in exposing the ethical issues surrounding the use of human cells in research. He was instrumental in bringing attention to the HeLa cell line, which was derived from Henrietta Lacks without her consent in the 1950s. His efforts helped to highlight the importance of ethical standards in biomedical research and the need for informed consent from patients.